Berta Fernández Ledesma, Natalia Mendoza-Palomar, Susana Melendo Pérez, Aurora Fernández-Polo, Berta Renedo Miró, Alba Pau Parra, Sonia Luque Pardos, Santiago Grau Cerrato, Jaume Vima Bofarull, María Teresa Martín-Gómez, Montserrat Pujol Jover, Maria Isabel Benítez-Carbante, Cristina Díaz de Heredia, Pere Soler-Palacin
Isavuconazole (ISA) is approved for treating invasive aspergillosis and mucormycosis in adults, but its use in children remains off-label. We report on the use of ISA in real-world pediatric practice with 15 patients receiving ISA for treatment of invasive fungal infections. Therapeutic drug monitoring (TDM) was performed in all patients, with 52/111 (46.8%) Ctrough determinations out of range, thus supporting the need for TDM in children, especially those receiving extracorporeal membrane oxygenation (ECMO)...
November 14, 2023: Antimicrobial Agents and Chemotherapy